Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc. (United States) is linked to 1 FDA-registered manufacturing site. 6 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Takeda Pharmaceuticals U.S.A., Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/takeda-pharmaceuticals-u-s-a-inc

Overview

Takeda Pharmaceuticals U.S.A., Inc. is a subsidiary of Takeda Pharmaceutical Company Limited, which is a global leader in the pharmaceutical industry. The company focuses on manufacturing and distributing innovative healthcare products to improve patient outcomes across various therapeutic areas.

Therapeutic areas

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Takeda Pharmaceuticals U.S.A., Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

6 FDA enforcement records linked to this company.

  • 4832016-09-09

    Submission of report follow-up

  • 4832016-09-09

    Late submission of 15-day report

  • 4832016-09-09

    Failure to review ADE information

  • 4832013-01-18

    Late submission of 15-day report

  • 4832013-01-18

    Failure to review ADE information

  • 4832013-01-18

    Submission of report follow-up

For suppliers

Is this Takeda Pharmaceuticals U.S.A., Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.